Moderna gets full US approval for COVID shot in at-risk children 6 months and older
Coronavirus,Coronavirus Vaccine,Vaccines,FDA
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration has granted full approval for Moderna's (MRNA.O), opens new tab COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
News
Mass Kidnappings, Covid Contingencies, ICE Controversies: Stories You May Have Missed
Malayna J. Bizier
June 18th, 2026
Red Blue Translator
Anti-vaxxer
Headline Roundup
Laid Off Meta Employees Sue Company for Using AI to Target Workers Who Took Leave
July 16th, 2026